To determine whether our above findings have a potential translational significance, we performed two separate sets of experiments to determine Kindlin-2 KD in the liver via tail vein injection of AAV8 expressing a Kindlin-2 shRNA (AAV8-shK2) can attenuate the NAFLD in mice. The gene discussed is FERMT2; the disease is metabolic dysfunction-associated steatotic liver disease.